Is there a 'treatment gap' in acute coronary syndromes?
Brian R
BR
Krause
Roger S
RS
Newton
D000208:Acute Disease; D000789:Angina, Unstable / Q000097:blood / Q000188:drug therapy* / Q000201:enzymology; D000818:Animals; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D016632:Apolipoprotein A-I / Q000627:therapeutic use; D008078:Cholesterol, LDL / Q000097:blood; D003331:Coronary Vessels / Q000473:pathology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy* / Q000201:enzymology; D013577:Syndrome
D000924:Anticholesteremic Agents; D016632:Apolipoprotein A-I; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors